March 5th online at 14 – 15 (Finland time) Sirpa Jalkanen, Professor, Academician, University of Turku: The thrill of searching and joy of finding Flyer Registration link: https://link.webropolsurveys.com/S/819786AD6D640B9D…
BioCity Turku asks for proposals for Elias Tillandz publication prize winner during February 2024
In the context of the 33rd BioCity Symposium (29-30 August 2024) the twentieth Elias Tillandz prize will be awarded for the best scientific paper published in 2023 in Turku. …
Coffey lab awarded 360,000$ from Michael J. Fox Foundation to Improve Patient Diagnosis and Monitoring in Parkinson’s Disease
The lab identified that LRRK2, a kinase that plays a central role in familial and sporadic Parkinson’s Disease, controls the cellular machinery that is responsible for translating genetic code into…
Turku Screening Unit Receives Funding to Establish Single Objective Light Sheet for longitudinal and dynamic screening of complex 3D cell systems
The Research Council of Finland awarded an infrastructure grant to the Turku Screening Unit as a part of the EU-OPENSCREEN-FINLAND consortium. The funding awarded to the Turku Screening Unit is…
Frontiers of Science seminars will start the spring season on Thursday 2 February at 12:00
Frontiers of Science spring seminars are starting again. All seminars are on-site only at 12:00 in BioCity, Presidentti auditorium, if not stated otherwise. Coffee and sandwich is served before each…
Frontiers of Science seminars will start on Thursday 1 February 2024
Frontiers of Science seminar program is ready for spring 2024. All seminars are on-site only at 12:00 in BioCity, Presidentti auditorium. Coffee and sandwich are served before each seminar.
Distinguished Innovator Grant from Novo Nordisk to the research team of John Eriksson
Professor John Eriksson and his research team have received the prestigious Distinguished Innovator grant of 6 million DKK (approximately 800 000 euro) from Novo Nordisk to support their project titled,…
Novo Nordisk Fonden funding to Westermarck and Ventelä teams to develop new cancer biomarker for clinical use
Different cancers have very different impact on the patient well-being. However, most of them are treated similarly, even though better treatment results could be achieved by more personalized treatment strategies.
The Brain Gain Programme, apply by 31 January 2024
Bringing international medical research excellence to Finland – one researcher at a time! The Brain Gain programme fills an important gap in the field of research funding and provides an…
Phuong Doan from Westermarck group was selected for a postdoctoral cancer researcher position
Phuong Doan from Jukka Westermarck’s research group was selected for a postdoctoral cancer researcher position funded by the K. Albin Johansson Foundation and Cancer Foundation Finland in September 2023 call.